Group 1 - The company, Hanyu Pharmaceutical, is making continuous breakthroughs in the field of innovative drug research and development [2] - On July 31, the company established a strategic cooperation with Borui Pharmaceutical to enhance collaboration in the development and commercialization of peptide drugs, aiming for resource sharing and joint development [2] - The company has made progress in its self-developed innovative drug projects, including the completion of process development for the raw materials of the weight loss drug HY3003 and the initiation of research on various dosage forms [2] Group 2 - The nasal spray drug HY3000 has entered the clinical phase III [2] - The company is collaborating with Sinopharm on the research and development of Cannabidiol (CBD) drugs in the CNS field [2]